REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy

Clinical trial NCT00087646 · COMPLETED

Trial details

NCT number: NCT00087646
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2003-09-01
Primary completion: 2008-05-01
Enrollment: 948

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.